Inpatient Small Bowel Capsule Endoscopy and Its Impact on Bleeding and Readmission
Author Information
Author(s): Muacevic Alexander, Adler John R, Ghafary Ismail, Seoud Talal, Jorgensen Michael, Marhaba Jade, Briggs William M, Jamorabo Daniel S
Primary Institution: Stony Brook University
Hypothesis
Does using small bowel capsule endoscopy (SBCE) significantly improve the identification of potential bleeding sites or reduce the risk of 30-day readmission for gastrointestinal bleeding?
Conclusion
Inpatient SBCE did not significantly affect 30-day readmission rates, even when a bleeding site was identified and treated.
Supporting Evidence
- 514 inpatients underwent SBCE over a 10-year period.
- 40.7% of patients who underwent SBCE had subsequent endoscopic procedures.
- 80.4% of those who had procedures had a bleeding site identified and treated.
- Subsequent procedures increased hospital stay without reducing readmission risk.
- Patients on anticoagulation therapy were older but did not have a higher readmission risk.
Takeaway
The study found that using a special camera to look for bleeding in the small intestine while patients are in the hospital didn't help them avoid going back to the hospital later.
Methodology
This was a single-center retrospective cohort study involving inpatients who underwent SBCE for suspected small bowel bleeding.
Potential Biases
Selection bias is inherent in retrospective studies.
Limitations
The study is retrospective and conducted at a single center, which may limit generalizability.
Participant Demographics
The mean age was 73 years, with 58.4% men and 88.7% white non-Hispanic individuals.
Statistical Information
P-Value
p = 0.2
Confidence Interval
95% CI 0.9-1.9
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website